Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT04920851
NCT04920851UnknownNot Applicable

Comparison of Cytokine Hemadsorption as an Immunomodulator Therapy in Covid 19 Patients With and Without Bacterial Sepsis

Derince Training and Research Hospital1 site in 1 country23 target enrollmentStarted: June 10, 2021Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
23
Locations
1
Primary Endpoint
interleukin 6
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

In this retrospective study, we aimed to compare the laboratory and clinical results of cytokine hemadsorption as an immunomodulation therapy in COVID-19 ICU patients with or without sepsis.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •COVID-19 patients were the available data of laboratory diagnosis of COVID-19 (a positive throat swab nucleic acid test or positive serum COVID-19 specific antibody test),
  • •patients with COVID-19 induced sepsis was detection of bacterial agent in blood or tracheal culture

Exclusion Criteria

  • •below 18 aged
  • •those who did not undergo hemoperfusion

Outcomes

Primary Outcomes

interleukin 6

Time Frame: 1 month

level of interleukin 6

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Derince Training and Research Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

İLKE KÜPELİ

ASSOC. PROF

Biruni University

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Effectiveness of the Cytokine Hemadsorption on SepsisInterleukin-6
NCT05057455Biruni University39
Unknown
Not Applicable
Influence of Thyroid Hormones on the Woundhealing ProcessThyroid NeoplasmsThyroid Carcinoma
NCT00929318Hannover Medical School26
Recruiting
Not Applicable
Immunoadsorption Versus Plasma Exchange for Treatment of Guillain-Barré Syndrome (GBS)GBS
NCT04871035University of Ulm20
Active, not recruiting
Not Applicable
Compare Clinical Outcomes Between Advanced Immunotherapy and Classical Immunochemotherapy in RRMMMyeloma Multiple
NCT06205823Seoul St. Mary's Hospital1,600
Terminated
Not Applicable
Immunoadsorption in Patients With Severe Systemic SclerosisSystemic Scleroderma
NCT01410903GWT-TUD GmbH1